- 24 November 2020
- Transport / Logistics Services
Ahead of the expected demand for cold chain COVID-19 vaccine deliveries, UPS has authorised UPS Healthcare to produce up to 545kg of dry ice per hour in its US facilities.
Two of the first vaccines to face licensing need to be stored and transported at extremely low temperatures. With millions of doses being ordered around the world, this could well cause a dry ice shortage in supply chains.
The dry ice production will enable vaccines to be supplied to US and Canadian hospitals and healthcare facilities.
“Enhancing our dry ice production capabilities increases our supply chain agility and reliability immensely when it comes to handling complex vaccines for our customers,” says Wes Wheeler, president of UPS Healthcare. “Healthcare facilities in Louisville, Dallas and Ontario will ensure we have the capability to produce dry ice to sufficiently pack and replenish shipments as needed to keep products viable and effective.”